Editorial
doi: 10.1056/NEJMe1004430.
Epub 2010 Jun 5.
Even better kinase inhibitors for chronic myeloid leukemia
- PMID: 20525994
- DOI: 10.1056/NEJMe1004430
Item in Clipboard
Editorial
Even better kinase inhibitors for chronic myeloid leukemia
N Engl J Med.
.
No abstract available
Comment on
-
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Clinical Trial.
-
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.N Engl J Med. 2010 Jun 17;362(24):2260-70. doi: 10.1056/NEJMoa1002315. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525995 Clinical Trial.
Similar articles
-
Second-generation BCR-ABL kinase inhibitors in CML.N Engl J Med. 2010 Oct 21;363(17):1672-3; author reply 1673-5. doi: 10.1056/NEJMc1007927. N Engl J Med. 2010. PMID: 20973144 No abstract available.
-
Second-generation BCR-ABL kinase inhibitors in CML.N Engl J Med. 2010 Oct 21;363(17):1673; author reply 1673-5. doi: 10.1056/NEJMc1007927. N Engl J Med. 2010. PMID: 20973145 No abstract available.
-
Second-generation BCR-ABL kinase inhibitors in CML.N Engl J Med. 2010 Oct 21;363(17):1672; author reply 1673-5. doi: 10.1056/NEJMc1007927. N Engl J Med. 2010. PMID: 20961253 No abstract available.
-
Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase.Cancer. 2010 Mar 15;116(6):1419-30. doi: 10.1002/cncr.24928. Cancer. 2010. PMID: 20120030 Review.
-
[Therapeutic drug management of BCR-ABL tyrosine kinase inhibitor for chronic myeloid leukemia patients].Rinsho Ketsueki. 2013 Oct;54(10):1720-9. Rinsho Ketsueki. 2013. PMID: 24064822 Review. Japanese. No abstract available.
Cited by
-
ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.Cell Stem Cell. 2016 Aug 4;19(2):177-191. doi: 10.1016/j.stem.2016.05.004. Epub 2016 Jun 9. Cell Stem Cell. 2016. PMID: 27292188 Free PMC article.
-
Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells.Iran J Basic Med Sci. 2019 Jun;22(6):581-589. doi: 10.22038/ijbms.2019.31879.7666. Iran J Basic Med Sci. 2019. PMID: 31231484 Free PMC article. Review.
-
Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease?Sultan Qaboos Univ Med J. 2012 Nov;12(4):422-8. doi: 10.12816/0003166. Epub 2012 Nov 20. Sultan Qaboos Univ Med J. 2012. PMID: 23275837 Free PMC article.
-
The challenge of developing robust drugs to overcome resistance.Drug Discov Today. 2011 Sep;16(17-18):755-61. doi: 10.1016/j.drudis.2011.07.001. Epub 2011 Jul 19. Drug Discov Today. 2011. PMID: 21784168 Free PMC article.
-
Con: the case for expanded lung cancer research support.Am J Respir Crit Care Med. 2011 Dec 1;184(11):1234-6. doi: 10.1164/rccm.201104-0697ED. Am J Respir Crit Care Med. 2011. PMID: 22162887 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
